Literature DB >> 10480718

Eradication of Taenia solium cysticercosis: a role for vaccination of pigs.

M W Lightowlers1.   

Abstract

Neurocysticercosis due to Taenia solium is an important cause of human morbidity and mortality, particularly in Latin America and parts of Africa and Asia. The disease has been recognised as potentially eradicable. Emphasis has been placed on control of the parasite through mass chemotherapy of human populations to remove tapeworm carriers. This strategy does not control the source of tapeworm infections, cysticercosis in pigs, and parasite transmission may continue due to incomplete chemotherapy coverage of human tapeworm carriers or because of immigration of tapeworm carriers into control areas. Exceptionally effective, practical vaccines have been developed against cysticercosis in sheep and cattle and a recent trial has proved recombinant antigens to be effective against Taenia solium cysticercosis in pigs. A new strategy for eradication of Taenia solium is proposed, based principally on a combined approach of chemotherapy of human tapeworm carriers and vaccination of all pigs at risk of infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480718     DOI: 10.1016/s0020-7519(99)00051-x

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  13 in total

Review 1.  Neurocysticercosis--New Millennium, ancient disease and unending debate.

Authors:  G Narula; K S Bawa
Journal:  Indian J Pediatr       Date:  2003-04       Impact factor: 1.967

2.  Evaluating the efficacy of teaching methods regarding prevention of human epilepsy caused by Taenia solium neurocysticercosis in Western Kenya.

Authors:  Jared Wohlgemut; Cate Dewey; Mike Levy; Florence Mutua
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

3.  Characterization and protective potential of the immune response to Taenia solium paramyosin in a murine model of cysticercosis.

Authors:  J Vázquez-Talavera; C F Solís; L I Terrazas; J P Laclette
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Heterologous prime-boost oral immunization with GK-1 peptide from Taenia crassiceps cysticerci induces protective immunity.

Authors:  Gladis Fragoso; Fernando Esquivel-Guadarrama; M Angélica Santana; Raul J Bobes; Beatriz Hernández; Jacquelynne Cervantes; René Segura; Fernando A Goldbaum; Edda Sciutto; Gabriela Rosas
Journal:  Clin Vaccine Immunol       Date:  2011-05-18

5.  Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response.

Authors:  A Toledo; G Fragoso; G Rosas; M Hernández; G Gevorkian; F López-Casillas; B Hernández; G Acero; M Huerta; C Larralde; E Sciutto
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens.

Authors:  Ana Flisser; Charles G Gauci; André Zoli; Joel Martinez-Ocaña; Adriana Garza-Rodriguez; Jose Luis Dominguez-Alpizar; Pablo Maravilla; Rossana Rodriguez-Canul; Guillermina Avila; Laura Aguilar-Vega; Craig Kyngdon; Stanny Geerts; Marshall W Lightowlers
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon.

Authors:  Emmanuel Assana; Craig T Kyngdon; Charles G Gauci; Stanny Geerts; Pierre Dorny; Redgi De Deken; Garry A Anderson; André P Zoli; Marshall W Lightowlers
Journal:  Int J Parasitol       Date:  2010-02-04       Impact factor: 3.981

8.  Antibody responses to the host-protective Taenia solium oncosphere protein TSOL18 in pigs are directed against conformational epitopes.

Authors:  E Assana; C G Gauci; C T Kyngdon; A P Zoli; P Dorny; S Geerts; M W Lightowlers
Journal:  Parasite Immunol       Date:  2010-06       Impact factor: 2.280

9.  Protection against Asiatic Taenia solium induced by a recombinant 45W-4B protein.

Authors:  Xuenong Luo; Yadong Zheng; Junling Hou; Shaohua Zhang; Xuepeng Cai
Journal:  Clin Vaccine Immunol       Date:  2008-12-17

10.  Vaccine development against the Taenia solium parasite: the role of recombinant protein expression in Escherichia coli.

Authors:  Charles Gauci; César Jayashi; Marshall W Lightowlers
Journal:  Bioengineered       Date:  2012-11-29       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.